Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors.

Abstract excerpt

KRAS gene mutation is widespread in tumors and plays an important role in various malignancies. Targeting KRAS mutations is regarded as the "holy grail" of targeted cancer therapies. Recently, multiple strategies, including covalent binding strategy, targeted protein degradation strategy, targeting protein and protein interaction strategy, salt bridge strategy, and multivalent strategy, have been adopted to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Discovery
• Share to Mutation
• Share to Proteolysis